Advertisement
Global pharmaceutical company AstraZeneca has announced a fresh investment of INR 176 crore in India to expand its Global Innovation & Technology Centre (GITC) in Chennai. This marks the firm's third major investment in the country within two years. The move aims to strengthen AstraZeneca's global healthcare innovation presence, foster digital capabilities, and support advanced technology-led healthcare solutions. The initiative will also generate skilled employment opportunities and reinforce Chennai's position as a leading hub for global innovation.
Global pharma major AstraZeneca confirmed earlier this week that it would invest INR 176 crore in India to expand capabilities and infrastructure at its Global Innovation & Technology Centre (GITC) in Chennai. This development represents the company's third round of investment in the country in the past two years. Advertisement
The company noted that the fresh capital infusion would allow the GITC to further consolidate its role as a leading hub for healthcare innovation, both globally and in India. The statement highlighted that the expansion would particularly strengthen AstraZeneca's efforts in cutting-edge healthcare solutions.
AstraZeneca India Pvt Ltd Managing Director, Siva Padmanabhan, explained that the investment demonstrated the company's continued mission to enhance patient lives by embedding advanced technologies into its work. He observed that Chennai was steadily evolving into an important innovation hub and added that the company's growth in the city underscored the state's vast potential.
The investment is set to support AstraZeneca's technology and innovation teams working across artificial intelligence, data analytics, machine learning, data science, and supply chain analytics. The company indicated that these areas would play a vital role in reshaping healthcare outcomes and accelerating the delivery of next-generation medicines. It also stressed that the initiative would back digital and data-driven solutions and contribute to building future-ready healthcare ecosystems.
Tamil Nadu Chief Minister M.K. Stalin, as quoted in the company's statement, remarked that AstraZeneca's additional investment reflected the state's status as a hub for global innovation. He noted that the development would generate skilled opportunities, foster knowledge exchange, and strengthen Tamil Nadu's image as a preferred destination for industries looking to the future.
In addition to its broad portfolio in oncology, cardiovascular, respiratory, and rare disease treatments, AstraZeneca pointed out that it had built a strong base in India for technology, global business services, and research and development. With the GITC included, the company confirmed that it employs over 5,000 people in the country.
The investment not only enhances the company's technological and research capabilities but also promises to create valuable employment and knowledge-sharing opportunities. By integrating digital solutions and advanced analytics, the pharmaceutical major is positioning itself to deliver more efficient, future-focused healthcare outcomes from its Indian operations.
Source - PTI
5th Jun, 2025
25th May, 2023
11th May, 2023
27th Apr, 2023
Advertisement
Facebook
Whatsapp
